Bryan College of Health Sciences Digital Archives

What current research can teach medical personnel about sepsis management and treatment

Show simple item record

dc.contributor.author Klein*, Emily
dc.contributor.author Holm, Ashley
dc.contributor.author Aguilar, Brianna
dc.contributor.author Robinson, Brittany
dc.date.accessioned 2019-11-22T21:40:46Z
dc.date.available 2019-11-22T21:40:46Z
dc.date.issued 2019-04-12
dc.identifier.citation Klein, E., Robinson, B., Holm, A., Aguilar, B. What current research can teach medical personnel about sepsis management and treatment. Paper presented at: Nebraska Academy of Sciences, One Hundred-Twenty-Ninth Annual Meeting; April 12, 2019; Lincoln, NE. https://digitalcommons.unl.edu/cgi/viewcontent.cgi?article=1014&context=nasproc. Accessed November 21, 2019. en_US
dc.identifier.uri https://digitalcommons.unl.edu/cgi/viewcontent.cgi?article=1014&context=nasproc
dc.identifier.uri http://hdl.handle.net/20.500.11987/364
dc.description.abstract Do patients diagnosed with severe sepsis who are treated with hydrocortisone, thiamine, and vitamin C have a better prognosis than those treated with the current standard practice? Through extensive searching of the Cochrane Collection, PubMed, and the Bryan College of Health Sciences Library, this medication regimen effectiveness was analyzed. To research this regimen, three primary research articles were chosen. Because this topic is new, available research was limited. Criteria for the primary article included the full medication regimen, a critical care setting, and the diagnosis and prognosis of sepsis. Additionally, one systematic review was chosen that analyzed the effectiveness of hydrocortisone in the treatment of sepsis. To supplement the article and systematic review, a critical care nurse was interviewed. With over 30 years of experience in the intensive cardiac unit at an urban hospital, she detailed her experiences with sepsis and shared that this protocol has been in discussion at intensive care conventions. Through research, we found that this protocol decreased mortality by 32%, decreased the need for dialysis by 17%, and decreased vasopressor use by an average of 35 hours. Ultimately, the current research on this medication regimen shows great potential in benefiting patient outcomes. en_US
dc.language.iso en_US en_US
dc.publisher Nebraska Academy of Sciences en_US
dc.subject Sepsis en_US
dc.subject Septicemia en_US
dc.subject Hydrocortisone en_US
dc.subject Thiamine en_US
dc.subject Vitamin C en_US
dc.title What current research can teach medical personnel about sepsis management and treatment en_US
dc.type Conference Presentation en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search


Browse

My Account